3M Co (MMM) stock
MMMNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 20, 2026Score 14/3019% above fair value
$183.66−2.58 (-1.39%)
Close on Nov 13, 2026Market cap $94.90BP/E 27.4Yield 1.59%
3M r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2024 it was $700.00M, up 0.0% from the year before. Over ten years it grew -5.2% a year on average. The highest annual figure on record is $1.35B in fiscal 2017.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $700.00M | 0.0% |
| FY2023 | Dec 31, 2023 | $700.00M | -12.5% |
| FY2022 | Dec 31, 2022 | $800.00M | -33.3% |
| FY2021 | Dec 31, 2021 | $1.20B | +9.1% |
| FY2020 | Dec 31, 2020 | $1.10B | -12.2% |
| FY2019 | Dec 31, 2019 | $1.25B | 0.0% |
| FY2018 | Dec 31, 2018 | $1.25B | -7.3% |
| FY2017 | Dec 31, 2017 | $1.35B | +8.3% |
| FY2016 | Dec 31, 2016 | $1.25B | +2.0% |
| FY2015 | Dec 31, 2015 | $1.22B | +2.5% |
| FY2014 | Dec 31, 2014 | $1.19B | +3.7% |
| FY2013 | Dec 31, 2013 | $1.15B | +6.6% |
| FY2012 | Dec 31, 2012 | $1.08B | +4.2% |
| FY2011 | Dec 31, 2011 | $1.04B | +12.7% |
| FY2010 | Dec 31, 2010 | $919.00M | +9.7% |
| FY2009 | Dec 31, 2009 | $838.00M | -1.5% |
| FY2008 | Dec 31, 2008 | $851.00M | – |
See a number that looks wrong?